Holen Sie sich die Stockscreener-App
69.62
1.22%
0.841
Schlusskurs vom Vortag:
$68.78
Offen:
$69.5
24-Stunden-Volumen:
16,746
Relative Volume:
0.55
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.83%
1M Leistung:
+6.00%
6M Leistung:
+57.54%
1J Leistung:
+71.88%
1-Tages-Spanne:
$68.72
$69.71
1-Wochen-Bereich:
$68.72
$71.10
52-Wochen-Spanne:
$40.17
$71.10
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
69.62 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
377.99 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.64 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.10 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
288.99 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
749.58 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
NASDAQ New 52-Week Highs And Lows - Moomoo
Top ETFs to Watch - TradingKey
Top ETFs: Live Prices, Returns & Trends - TradingKey
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets - Benzinga
The Technical Signals Behind (GNOM) That Institutions Follow - Stock Traders Daily
The Next Big Theme: September 2026 - Global X ETFs
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) Stock Price, News & Analysis - Kalkine
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
7 Best Biotech ETFs to Buy Now | Investing - US News Money
(GNOM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Through The Systematic Lens: Thematic Equity: Factor Landscape (August 2026) - Seeking Alpha
Through the Systematic Lens: Thematic Equity: Factor Landscape (August 2026) - Global X ETFs
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
Healthcare ETFs rally as Moderna nearly doubles on melanoma win - Seeking Alpha
Global X Genomics & Biotechnology UCITS ETFUSDChart Real-time | ETF | GNOG | IE00BM8R0N95 - marketscreener.com
The Next Big Theme: August 2026 - Global X ETFs
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Genomics & Biotechnology ETF (GNOM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Global X Genomics & Biotechnology Etf (GNOM) Risk Zones - Stock Traders Daily
GNOM Dividend: 1.12% Yield, $0.65/Share — History & Dates - GuruFocus
GNOMZ ETF Profile: Dividends, Returns (AQUISUK:GNOMZ) - TradingView
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.16666667 Sh - TradingView
Technical Reactions to GNOM Trends in Macro Strategies - Stock Traders Daily
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Caribou Biosciences Inc (CRBU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):